DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Size: px
Start display at page:

Download "DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD"

Transcription

1 STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with multiple (2+) risk factors Perform 10-year risk assessment For patients with 0 1 risk factor 10 year risk assessment not required Most patients have 10-year risk <10% 1

2 Modifiable risks Cardiovascular Disease Hypertension CAD/CHF Diabetes Dyslipidemia High total Cholesterol and/or Low HDL Atrial Fibrillation Asymptomatic Carotid Artery Stenosis Cigarette smoking Sickle Cell Disease Dietary Factors Obesity Physical Activity Hormone Replacement Therapy Less Well-Documented or Potentially Modifiable Risk Factors Metabolic syndrome Alcohol abuse Hyperhomocysteinemia Drug abuse Hypercoagulability Oral contraceptive use Inflammatory processes Periodontal disease, C pneumoniae, Cytomegalovirus, H pylori CagA seropositivity, Acute infection, elevated hs-crp Migraine Sleep disordered breathing AGE Non-modifiable risks Doubling of stroke rate each 10 years after age 55 White Black Men Women Men Women Prevalence (per 100,000) 2

3 Equating risk factors with actual risk Patients should have stroke risk assessment (Class I, Level A) Risk assessment tools should be considered (Class IIa, Level B) Helps identify individuals who could benefit from therapeutic interventions and who may not be treated on the basis of any 1 risk factor ASSESSMENT OF CHD RISK For persons without known CHD, other forms of atherosclerotic disease, or diabetes: Count the number of risk factors: Cigarette smoking Hypertension (BP 140/90 mmhg or on antihypertensive medication) Low HDL cholesterol (<40 mg/dl) Family history of premature CHD o CHD in male first degree relative <55 years o CHD in female first degree relative <65 years Age (men 45 years; women 55 years) Use Framingham scoring for persons with 2 risk factors* (or with metabolic syndrome) to determine the absolute 10-year CHD risk. (downloadable risk algorithms at Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 2001;285: , Professional Postgraduate Services MODIFIED APPROACH TO CHD RISK ASSESSMENT LOW RISK designated as <0.6% CHD risk per year (<6% in 10 years) INTERMEDIATE RISK designated as a CHD risk of 0.6%- 2.0% per year (6-20% over 10 years) HIGH RISK designated as a CHD risk of >2% per year (20% in 10 years) (CHD risk equivalent), including those with CVD, diabetes, and PAD Greenland P et al. Circulation 2001; 104:

4 Modified Framingham Stroke Risk Profile (men) Points _ Age SBP (Untreated) SBP (Treated) Diabetes No Yes Cigarette No Yes CVD No Yes A Fib No Yes LVH on No Yes EKG Modified Framingham Stroke Risk Score 10-Year Probability, % Points Men Women Year Probability, % Points Men Women Risk Factor High Risk Caution Low Risk Blood Pressure > 140/ /80-89 <120/80 or I don t know Cholesterol > <200 or I don t know Diabetes Yes Borderline No Smoking I still smoke Atrial Fibrillation I have an irregular I don t know My heartbeat is heartbeat regular Diet I am overweight I am slightly My weight is overweight healthy Exercise I am a couch potato I exercise sometimes I exercise regularly I have stroke in Yes not sure no My family Score (each box=1) 4

5 Risk assessment tool pitfalls Each tool has limitations Do not account for all risk factors Need to be validated against different ethnic/race groups Have not yet been shown to improve stroke prevention programs Examination: Height: 6 ft 2 in Weight: 220 lb (BMI 28 kg/m 2 ) Waist circumference: 41 in BP: 150/88 mm Hg P: 64 bpm RR: 12 breaths/min Cardiopulmonary exam: normal Laboratory results: TC: 220 mg/dl HDL-C: 36 mg/dl LDL-C: 140 mg/dl TG: FBS: 220 mg/dl 120 mg/dl PRESENTATION WHAT IS WJC S 10-YEAR ABSOLUTE RISK OF FATAL/NONFATAL MI? A 12% absolute risk is derived from points assigned in Framingham Risk Scoring to: Age: 6 TC: 3 HDL-C: 2 SBP: 2 Total: 13 points In 1992 he exercised 14 minutes in a Bruce protocol exercise stress test to 91% of his maximum predicted heart rate without any abnormal ECG changes. He started on a statin in But in Sept 2004, he needed urgent coronary bypass surgery. 5

6 CHD RISK EQUIVALENTS Risk for major coronary events equal to that in established CHD 10-year risk for hard CHD >20% Hard CHD = myocardial infarction + coronary death DIABETES AS A CHD RISK EQUIVALENT 10-year risk for CHD 20% High mortality with established CHD High mortality with acute MI High mortality post acute MI CHD RISK EQUIVALENTS Other clinical forms of atherosclerotic disease (peripheral arterial disease, abdominal aortic aneurysm, and symptomatic carotid artery disease) Diabetes Multiple risk factors that confer a >20% 10-year risk for CHD 6

7 NOT ALL INDIVIDUALS WITH CORONARY HEART DISEASE HAVE TRADITIONAL RISK FACTORS 3 RF 9% 4 RF 1% 0 RF 19% 2 RF 28% 1 RF 43% Khot et al. JAMA 2003 Is there clinical evidence that novel risk markers predict future coronary events and provide additional predictive information beyond traditional risk factors? THE FUTURE OF CARDIAC BIOMARKERS Many experts are advocating the move towards a multimarker strategy for the purposes of diagnosis, prognosis, and treatment design As the pathophysiology of ACS is heterogeneous, so must be the diagnostic strategies 7

8 RISK ASSESSMENT IN PRACTICE Standard risk factors alone or in combination do not predict global risk well enough o Too many events in too many lower risk individuals o Modest screening performance Insufficient data at the present time to recommend novel biomarkers to screen the population at large, but selected intermediate risk populations may be appropriate. TREATMENT SUMMARY Individual biomarkers do not markedly improve risk prediction Markers of existing disease most promising (including imaging tools) Combining individual markers that reflect distinct biological pathways is a promising strategy, with several caveats Combining multiple mediocre markers will not work Not close to ready for clinical application Cost-effectiveness and outcome studies needed STROKE AS A RISK EQUIVALENT: PERCENTAGE OF PARTICIPANTS WITH LEVELS OF RISK BY AGE (DATA FROM REGARDS Lackland et.al Stroke 43: ,

9 STROKE AS CHD RISK EQUIVALENT Patients with atherosclerotic stroke should be included among those deemed to be at high risk (20% over 10 years) of further atherosclerotic coronary events. For the purposes of primary prevention, ischemic stroke should be included among cardiovascular disease outcomes in absolute risk assessment algorithms. The inclusion of atherosclerotic ischemic stroke as a high-risk condition and the inclusion of ischemic stroke more broadly as an outcome will likely have important implications for prevention of cardiovascular disease, because the number of patients considered to be at high risk would grow substantially. (Stroke.2012;43:00-00.) Large-vessel atherosclerotic ischemic stroke should be considered as a CHD risk equivalent similar to other atherosclerotic conditions in risk prediction instruments and guidelines that use CHD risk equivalents (Class I; Level of Evidence B). Ischemic stroke can reasonably be considered a relevant outcome along with CHD outcomes in CVD risk prediction instruments used in primary and secondary prevention, including trials of general preventive strategies not focused on particular blood vessels (Class IIa; Level of Evidence B). 9

10 Ischemic stroke subtypes other than large-vessel atherosclerosis, including small-vessel disease, may be considered CHD risk equivalents, although further research is needed (Class IIb; Level of Evidence B). Hemorrhagic strokes and strokes of undetermined subtypes may be included among outcomes in general CVD risk prediction instruments used in primary and secondary prevention (Class IIb; Level of Evidence B). Ischemic stroke can reasonably be considered a relevant outcome in clinical 10-year cardiovascular risk prediction instruments for patients (Class IIa; Level of Evidence B). 10

11 Further clinical epidemiological studies are needed to increase the level of evidence to improve precision of the absolute risk estimates for different stroke subtypes in risk prediction instruments. Approach to Secondary Stroke Prevention Components: Evaluate the Event Implement Interventions Initiate Medications Modify Stroke Risk Factor: Continuous Monitoring Treating Hypertension to Prevent Stroke HTN is the single most important modifiable risk factor for stroke HTN contributes to 70% of all strokes 11

12 Benefits of Treating Hypertension Younger than 60 yrs Reduces the risk of stroke by 42% Reduces the risk of coronary event by 14% Older than 60yrs Reduces overall mortality by 20% Reduces cardiovascular mortality by 33% Reduces incidence of stroke by 40% Reduces coronary artery disease by 15% Treat Hypertension Aggressively Target most patients still < 140/90 Home Measurement: < 135/85 Diabetics or chronic kidney disease: < 130/80 Lifestyle Modification: Sodium restriction, DASH diet, physical activity, weight loss, alcohol restriction, smoking cessation Expect to use combination therapy ACE inhibitor, ARB, diuretic 12

High Blood Cholesterol

High Blood Cholesterol National Cholesterol Education Program ATP III Guidelines At-A-Glance Quick Desk Reference 1 Step 1 2 Step 2 3 Step 3 Determine lipoprotein levels obtain complete lipoprotein profile after 9- to 12-hour

More information

An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia

An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia Introduction Executive Summary The International Atherosclerosis Society (IAS) here updates

More information

Body Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ

Body Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ Body Composition & Longevity Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ LONGEVITY Genetic 25% Environmental Lifestyle Stress 75% BMI >30 OBESE 25-30 OVERWEIGHT 18-25 NORMAL WEIGHT 18

More information

Anticoagulation For Atrial Fibrillation

Anticoagulation For Atrial Fibrillation Anticoagulation For Atrial Fibrillation New Agents In A New Era Arjun V Gururaj, MD Arrhythmia and Electrophysiology Nevada Heart and Vascular Center Disclosures Biotronik Speaker Clinical investigator

More information

THE THIRD REPORT OF THE EXpert

THE THIRD REPORT OF THE EXpert SPECIAL COMMUNICATION Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults

More information

High Blood Cholesterol What you need to know

High Blood Cholesterol What you need to know National Cholesterol Education Program High Blood Cholesterol What you need to know Why Is Cholesterol Important? Your blood cholesterol level has a lot to do with your chances of getting heart disease.

More information

A PATIENT S GUIDE TO SECONDARY PREVENTION IN ACUTE CORONARY SYNDROME (ACS)

A PATIENT S GUIDE TO SECONDARY PREVENTION IN ACUTE CORONARY SYNDROME (ACS) A PATIENT S GUIDE TO SECONDARY PREVENTION IN ACUTE CORONARY SYNDROME (ACS) This medicine is subject to additional monitoring. This will allow quick identification of new safety information. If you get

More information

An important first step in identifying those at risk for Cardiovascular disease The Accutrend Plus system: from the makers of the ACCU-CHEK and

An important first step in identifying those at risk for Cardiovascular disease The Accutrend Plus system: from the makers of the ACCU-CHEK and An important first step in identifying those at risk for Cardiovascular disease The Accutrend Plus system: from the makers of the ACCU-CHEK and CoaguChek systems Cardiovascular disease: the #1 killer in

More information

AMODEL FOR CORONARY HEART DISEASE AND STROKE WITH APPLICATIONS TO CRITICAL ILLNESS INSURANCE UNDERWRITING I: THE MODEL

AMODEL FOR CORONARY HEART DISEASE AND STROKE WITH APPLICATIONS TO CRITICAL ILLNESS INSURANCE UNDERWRITING I: THE MODEL AMODEL FOR CORONARY HEART DISEASE AND STROKE WITH APPLICATIONS TO CRITICAL ILLNESS INSURANCE UNDERWRITING I: THE MODEL Angus S. Macdonald,* Howard R. Waters, and Chessman T. Wekwete ABSTRACT In Part I

More information

Chronic diseases in low and middle income countries: more research or more action? Shah Ebrahim London School of Hygiene & Tropical Medicine

Chronic diseases in low and middle income countries: more research or more action? Shah Ebrahim London School of Hygiene & Tropical Medicine Chronic diseases in low and middle income countries: more research or more action? Shah Ebrahim London School of Hygiene & Tropical Medicine More action needed Overview Growing burden of chronic diseases

More information

CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN

CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN HOSPITALIZATION CASE #: 2 8 8 0 H FY288BH4CN Has the participant indicated any of the following reasons for being admitted overnight for this case? 1. Suspected or confirmed problems with the heart, circulation,

More information

UHS CLINICAL CARE COLLABORATION: Outpatient & Inpatient

UHS CLINICAL CARE COLLABORATION: Outpatient & Inpatient Guidelines for Anticoagulation Initiation and Management Y2014 UHS CLINICAL CARE COLLABORATION: Outpatient & Inpatient Topic Page Number MEDICATION FLOW AND PATIENT FLOW... 2 AND 3 PARENTERAL ANTICOAGULANTS...

More information

ACUTE STROKE REGISTRY (NJASR) VERSION 2.0) (Continued)

ACUTE STROKE REGISTRY (NJASR) VERSION 2.0) (Continued) New Jersey Department of Health ACUTE STROKE REGISTRY (NJASR) VERSION 2.0 A. DEMOGRAPHIC DATA *Hospital Type (1): 1=Primary 2=Comprehensive 3=Other *Hospital Code (2): *Hospital Transferred From Code (3):

More information

Risk factors for peripheral artery disease

Risk factors for peripheral artery disease www.tasc-2-pad.org Risk factors for peripheral artery disease Based on the Inter-Society Consensus Edited by Dr Denis Clement University Hospital, Ghent, Belgium Supported by an educational grant from

More information

Using Family History to Improve Your Health Web Quest Abstract

Using Family History to Improve Your Health Web Quest Abstract Web Quest Abstract Students explore the Using Family History to Improve Your Health module on the Genetic Science Learning Center website to complete a web quest. Learning Objectives Chronic diseases such

More information

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 Definition, Prevalence, Pathophysiology and Complications of CKD JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 KI supplements January 2013 Objectives of the course on CKD:

More information

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What

More information

Medical Fitness. Annual Meeting December 2012. By: Deb Riggs, MEd, General Manager

Medical Fitness. Annual Meeting December 2012. By: Deb Riggs, MEd, General Manager Exercise is Medicine Referral Process Utilizing an EMR Medical Fitness Association Annual Meeting December 2012 By: Deb Riggs, MEd, General Manager Faculty Disclosure Deb Riggs Deb Riggs has listed no

More information

Anticoagulants in Atrial Fibrillation

Anticoagulants in Atrial Fibrillation Anticoagulants in Atrial Fibrillation Starting and Stopping Them Safely Carmine D Amico, D.O. Overview Learning objectives Introduction Basic concepts Treatment strategy & options Summary 1 Learning objectives

More information

ACCOUNTABLE CARE ORGANIZATION QUICK-REFERENCE SETUP GUIDE

ACCOUNTABLE CARE ORGANIZATION QUICK-REFERENCE SETUP GUIDE ACCOUNTABLE CARE ORGANIZATION QUICK-REFERENCE SETUP GUIDE V 9.0 eclinicalworks, 2013. All rights reserved Contents CONTENTS ACO SETUP 3 Demographics 3 ACO 12 4 ACO 13 6 ACO 14 7 ACO 15 8 ACO 16 9 ACO 17

More information

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA A CASE STUDY EXAMINING RISK FACTORS AND COSTS OF UNCONTROLLED HYPERTENSION ISPOR 2013 WORKSHOP

More information

High Blood Pressure and Chronic Kidney Disease

High Blood Pressure and Chronic Kidney Disease High Blood Pressure and Chronic Kidney Disease For People with CKD Stages 1 4 www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney

More information

The Women s Health Initiative where are we a decade later?

The Women s Health Initiative where are we a decade later? The Women s Health Initiative where are we a decade later? Henry G. Burger MIMR-PHI Institute & Jean Hailes for Women s Health, Melbourne, Australia Disclosures: Henry Burger Sources of Funding Pharmaceutical

More information

INSTRUCTIONS CHECKLIST

INSTRUCTIONS CHECKLIST These instructions have been designed for you to simplify the application process. Read these instructions in full before you begin. If you have any questions, please call Medipac for further assistance

More information

The Practical Guide Identification, Evaluation, and Treatment of Overweight and Obesity in Adults

The Practical Guide Identification, Evaluation, and Treatment of Overweight and Obesity in Adults NHLBI Obesity Education Initiative The Practical Guide Identification, Evaluation, and Treatment of Overweight and Obesity in Adults NNAATTI IOONNAAL L I INNSSTTI ITTUUTTEES S OOF F HHEEAALLTTHH NNAAT

More information

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical

More information

Atrial Fibrillation: A Different Perspective. Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital

Atrial Fibrillation: A Different Perspective. Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital Atrial Fibrillation: A Different Perspective Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital Faculty/Presenter Disclosure Faculty: Dr. Michael Heffernan Relationships with commercial

More information

The Hypertension Treatment Center

The Hypertension Treatment Center Patricia F. Kao MD MS Asst Professor, EVMS Nephrology & HTN April 26, 2014 The Hypertension Treatment Center I have no conflicts of interest to disclose Objectives Describe the role of Hypertension Treatment

More information

Impact of a nurse telephone intervention among high cardiovascular risk health fair participants. Lisa H. Jensen, BSN, RN Colorado Prevention Center

Impact of a nurse telephone intervention among high cardiovascular risk health fair participants. Lisa H. Jensen, BSN, RN Colorado Prevention Center Impact of a nurse telephone intervention among high cardiovascular risk health fair participants Lisa H. Jensen, BSN, RN Colorado Prevention Center Co-authors Bonnie Leaman-Castillo PhD, Behavioral Scientist

More information

Antiplatelet and Antithrombotic Therapy. Dr Curry Grant Stroke Prevention Clinic Quinte Health Care

Antiplatelet and Antithrombotic Therapy. Dr Curry Grant Stroke Prevention Clinic Quinte Health Care Antiplatelet and Antithrombotic Therapy Dr Curry Grant Stroke Prevention Clinic Quinte Health Care Disclosure of Potential for Conflict of Interest Dr. F.C. Grant Atrial Fibrillation FINANCIAL DISCLOSURE:

More information

New Anticoagulants and GI bleeding

New Anticoagulants and GI bleeding New Anticoagulants and GI bleeding DR DANNY MYERS MD FRCP(C) CLINICAL ASSISTANT PROFESSOR OF MEDICINE, UBC Conflicts of Interest None I am unbiased in the use of NOAC s vs Warfarin based on risk benefit

More information

MedStar Family Choice Benefits Summary District of Columbia- Healthy Families WHAT YOU GET WHO CAN GET THIS BENEFIT BENEFIT

MedStar Family Choice Benefits Summary District of Columbia- Healthy Families WHAT YOU GET WHO CAN GET THIS BENEFIT BENEFIT Primary Care Services Specialist Services Laboratory & X-ray Services Hospital Services Pharmacy Services (prescription drugs) Emergency Services Preventive, acute, and chronic health care Services generally

More information

From Concept to Rapid Visualization a Data Analytics Case Study

From Concept to Rapid Visualization a Data Analytics Case Study From Concept to Rapid Visualization a Data Analytics Case Study Gregory Wozniak, PhD Director of Outcomes Analytics Health Outcomes Group American Medical Association The Journey Objectives Share experiences

More information

Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations

Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations Dardo E. Ferrara MD Cardiac Electrophysiology North Cascade Cardiology PeaceHealth Medical Group Which anticoagulant

More information

Ohio Health Homes Learning Community Meeting. Overview of Health Homes Measures

Ohio Health Homes Learning Community Meeting. Overview of Health Homes Measures Ohio Health Homes Learning Community Meeting Overview of Health Homes Measures Tuesday, March 5, 2013 Presenter: Amber Saldivar, MHSM Associate Director, Informatics Analysis Health Services Advisory Group,

More information

The Role of Insurance in Providing Access to Cardiac Care in Maryland. Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs

The Role of Insurance in Providing Access to Cardiac Care in Maryland. Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs The Role of Insurance in Providing Access to Cardiac Care in Maryland Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs Heart Disease Heart Disease is the leading cause of death

More information

Group Long Term Care Insurance Application Evidence of Insurability

Group Long Term Care Insurance Application Evidence of Insurability First Unum Life Insurance Company 666 Third Avenue, Suite 301 New York, New York 10017 FOR HOME OFFICE USE ONLY FN MI LN PN SN Group Long Term Care Insurance Application Evidence of Insurability Please

More information

YOUR GUIDE TO. H e a rt Disease. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute

YOUR GUIDE TO. H e a rt Disease. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute YOUR GUIDE TO Living Well Wi t h H e a rt Disease U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute NIH Publication No. 06 5270 November

More information

Universitätsklinik für Kardiologie. Test. Thomas M. Suter Akute Herzinsuffizienz Diagnostik und Therapie thomas.suter@insel.ch 1

Universitätsklinik für Kardiologie. Test. Thomas M. Suter Akute Herzinsuffizienz Diagnostik und Therapie thomas.suter@insel.ch 1 Test Thomas M. Suter Akute Herzinsuffizienz Diagnostik und Therapie thomas.suter@insel.ch 1 Heart Failure - Definition European Heart Journal (2008) 29, 2388 2442 Akute Herzinsuffizienz Diagnostik und

More information

Preventive Health Services

Preventive Health Services understanding Preventive Health Services For the most current version of this document, visit www.wellwithbluemt.com or www.bcbsmt.com. Preventive health services include evidence-based screenings, immunizations,

More information

PREFERRED UNDERWRITING CLASSIFICATIONS

PREFERRED UNDERWRITING CLASSIFICATIONS PREFERRED UNDERWRITING CLASSIFICATIONS term ADVISOR GUIDE ABOUT EQUITABLE LIFE OF CANADA Equitable Life is one of Canada s largest mutual life insurance companies. For generations we ve provided policyholders

More information

Atrial Fibrillation Patient Survey Online survey of AFib Patients 65+ Exploring Experiences with the Diagnosis and Treatment of AFib.

Atrial Fibrillation Patient Survey Online survey of AFib Patients 65+ Exploring Experiences with the Diagnosis and Treatment of AFib. Atrial Fibrillation Patient Survey Online survey of AFib Patients 65+ Exploring Experiences with the Diagnosis and Treatment of AFib September 2012 Objectives and Methodology Objectives Achieve better

More information

Lipid levels in patients hospitalized with coronary artery disease: An analysis of 136,905 hospitalizations in Get With The Guidelines

Lipid levels in patients hospitalized with coronary artery disease: An analysis of 136,905 hospitalizations in Get With The Guidelines Lipid levels in patients hospitalized with coronary artery disease: An analysis of 136,905 hospitalizations in Get With The Guidelines Amit Sachdeva, MD, a Christopher P. Cannon, MD, b Prakash C. Deedwania,

More information

Depression in Older Persons

Depression in Older Persons Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression

More information

(TECHNICIANS) 4:30-5:30PM

(TECHNICIANS) 4:30-5:30PM E5. HIGH RISK PATIENTS, HIGH RISK MEDICATIONS: A FOCUS ON ANTICOAGULATION AND HEART FAILURE (TECHNICIANS) 4:30-5:30PM ACPE UAN: 0107-9999-15-040-L01-T 0.1 CEU/1.0 hr Activity Type: Knowledge-Based Learning

More information

9/5/14. Objectives. Atrial Fibrillation (AF)

9/5/14. Objectives. Atrial Fibrillation (AF) Novel Anticoagulation for Prevention of Stroke in Patients with Atrial Fibrillation Objectives 1. Review current evidence on use of warfarin in individuals with atrial fibrillation 2. Compare the three

More information

Preventive Care Coverage Wondering what preventive care your plan covers?

Preventive Care Coverage Wondering what preventive care your plan covers? STAYING WELL Regence BlueCross BlueShield of Oregon is an Independent Licensee of the Blue Cross and Blue Shield Association Preventive Care Coverage Wondering what preventive care your plan covers? Our

More information

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better Marian Taylor, M.D. Medical University of South Carolina Director, Cardiac Rehabilitation I have no disclosures.

More information

CARDIAC REHABILITATION Winnipeg Region Annual Report 2013-14

CARDIAC REHABILITATION Winnipeg Region Annual Report 2013-14 CARDIAC REHABILITATION Winnipeg Region Annual Report 2013-14 PROGRAM OVERVIEW The Cardiac Rehabilitation Program (CRP) operates out of two medical fitness facilities in Winnipeg, the Reh- Fit Centre and

More information

Healthy California 2020 Initiative: Consensus Building on Top Priority Areas for CDPH

Healthy California 2020 Initiative: Consensus Building on Top Priority Areas for CDPH Healthy California 2020 Initiative: Consensus Building on Top Priority Areas for CDPH Public Health Advisory Committee April 30, 2010 Introducing the CDPH Decision Framework Responding to public health

More information

Health Care Reform: Using preventive care for a healthier life

Health Care Reform: Using preventive care for a healthier life HorizonBlue.com Health Care Reform: Using preventive care for a healthier life Horizon Blue Cross Blue Shield of New Jersey is committed to empowering our members with access to preventive services to

More information

Prevents future health problems. You receive these services without having any specific symptoms.

Prevents future health problems. You receive these services without having any specific symptoms. Preventive Care To help you live the healthiest life possible, we offer free preventive services for most Network Health members. Please refer to your member materials, which you received when you enrolled

More information

Cholesterol and Triglycerides What You Should Know

Cholesterol and Triglycerides What You Should Know Cholesterol and Triglycerides What You Should Know Michael T. McDermott MD Professor of Medicine Endocrinology Practice Director Division of Endocrinology, Metabolism and Diabetes University of Colorado

More information

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation PATIENT EDUCATION GUIDE What is atrial fibrillation? Atrial fibrillation

More information

Chapter Three Accountable Care Organizations

Chapter Three Accountable Care Organizations Chapter Three Accountable Care Organizations One of the most talked-about changes in health care delivery in recent decades is Accountable Care Organizations, or ACOs. Having gained the attention of both

More information

Alternative Benefit Plan (ABP) ABP Cost-Sharing & Comparison to Standard Medicaid Services

Alternative Benefit Plan (ABP) ABP Cost-Sharing & Comparison to Standard Medicaid Services Alternative Benefit Plan (ABP) ABP Cost-Sharing & Comparison to Standard Medicaid Services Most adults who qualify for the Medicaid category known as the Other Adult Group receive services under the New

More information

Health Maintenance Guidelines for Women

Health Maintenance Guidelines for Women Health Maintenance Guidelines for Women Customize your plan: These guidelines apply to healthy women in the general population. The right plan for your care may differ based on your medical history, family

More information

Portable, cordless, single-channel ECG Monitor HCG-801-E

Portable, cordless, single-channel ECG Monitor HCG-801-E Portable, cordless, single-channel ECG Monitor HCG-801-E Screening & Self -Monitoring of cardiac events Compact - Cordless - Simple operation Fast - Discrete Records about 30 seconds heart rhythm and waveform

More information

Group Critical Illness Insurance Provides lump-sum cash benefits that can help with daily expenses

Group Critical Illness Insurance Provides lump-sum cash benefits that can help with daily expenses What can living with a critical illness mean to you? Daily out-of-pocket expenses for fighting the disease while still paying your bills! GROCERIES CAR HOME PRESCRIPTIONS Benefit coverage for A Plus Benefits

More information

Patient Intake Form. Patient Information. How did you find out about our office?

Patient Intake Form. Patient Information. How did you find out about our office? Atlanta Injury and Wellness Center 2740 Greenbriar Parkway Suite A 3 Atlanta, GA 30331 404 629 9999 Patient Intake Form Welcome to our office of chiropractic. Thank you for taking a moment to fill in our

More information

Health care reform update

Health care reform update Preventive services coverage Kaiser Foundation Health Plan of the Northwest has always offered broad, affordable coverage options that encourage members to seek care before a health condition becomes serious.

More information

STATE OF THE NATION. Challenges for 2015 and beyond. England

STATE OF THE NATION. Challenges for 2015 and beyond. England STATE OF THE NATION Challenges for 2015 and beyond England The state of the nation: diabetes in 2014 4 Care for children and young people 28 The challenges for 2015 and beyond: what needs to happen over

More information

Cardiac Rehabilitation

Cardiac Rehabilitation Cardiac Rehabilitation Exercise and Education Program Always thinking. Always caring. Cardiac Rehabilitation Dear Patient: Cardiac rehabilitation is an important part of your recovery. Our progressive

More information

New Anticoagulation Options for Stroke Prevention in Atrial Fibrillation. Joy Wahawisan, Pharm.D., BCPS April 25, 2012

New Anticoagulation Options for Stroke Prevention in Atrial Fibrillation. Joy Wahawisan, Pharm.D., BCPS April 25, 2012 New Anticoagulation Options for Stroke Prevention in Atrial Fibrillation Joy Wahawisan, Pharm.D., BCPS April 25, 2012 Stroke in Atrial Fibrillation % Stroke 1991;22:983. Age Range (years) CHADS 2 Risk

More information

4/9/2015. Risk Stratify Our Patients. Stroke Risk in AF: CHADS2 Scoring system JAMA 2001; 285: 2864-71

4/9/2015. Risk Stratify Our Patients. Stroke Risk in AF: CHADS2 Scoring system JAMA 2001; 285: 2864-71 Anticoagulation in the 21 st Century Adam Karpman, D.O. Saint Francis Medical Center/Oklahoma State University Medical Center Disclosures: None Atrial Fibrillation Most common arrhythmia in clinical practice.

More information

WOEST TRIAL- NO ASPIRIN IN STENTED PATIENTS REQUIRING ANTICOAGULATION. Van Crisco, MD, FACC, FSCAI First Coast

WOEST TRIAL- NO ASPIRIN IN STENTED PATIENTS REQUIRING ANTICOAGULATION. Van Crisco, MD, FACC, FSCAI First Coast WOEST TRIAL- NO ASPIRIN IN STENTED PATIENTS REQUIRING ANTICOAGULATION Van Crisco, MD, FACC, FSCAI First Coast Conflicts of Interest I have been a paid consultant and speaker for AstraZeneca, makers of

More information

HEALTH CARE COSTS 11

HEALTH CARE COSTS 11 2 Health Care Costs Chronic health problems account for a substantial part of health care costs. Annually, three diseases, cardiovascular disease (including stroke), cancer, and diabetes, make up about

More information

Genetic-Epidemiologic Study

Genetic-Epidemiologic Study Genetic-Epidemiologic Study of Early-onset Ischemic Heart Disease JAMES J. NORA, M.D., M.P.H., RANDALL H. LORTSCHER, M.D., RICHARD D. SPANGLER, M.D., AUDREY H. NORA, M.D., M.P.H., AND WILLIAM J. KIMBERLING,

More information

Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes NATIONAL DIABETES INFORMATION CLEARINGHOUSE

Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes NATIONAL DIABETES INFORMATION CLEARINGHOUSE NATIONAL DIABETES INFORMATION CLEARINGHOUSE Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes U.S. Department of Health and Human Services National Institutes of Health

More information

Understanding preventive care

Understanding preventive care Understanding preventive care We want you to be your healthiest. That s why the preventive services listed here are free for most members. What services are recommended? Know before you go. Preventive

More information

HEALTH CARE REFORM. Preventive Care. BlueCross BlueShield of South Carolina and BlueChoice HealthPlan of South Carolina

HEALTH CARE REFORM. Preventive Care. BlueCross BlueShield of South Carolina and BlueChoice HealthPlan of South Carolina HEALTH CARE REFORM Preventive Care BlueCross BlueShield of South Carolina and BlueChoice HealthPlan of South Carolina Preventive Care There was a time when an apple a day was the best preventive care advice

More information

Take advantage of preventive care to help manage your health

Take advantage of preventive care to help manage your health Take advantage of preventive care to help manage your health Preventing disease and detecting health issues at an early stage, if they occur, are important to living a healthy life. Following these recommended

More information

Alma Mater Studiorum Università di Bologna DOTTORATO DI RICERCA IN PSICOLOGIA GENERALE E CLINICA. Ciclo xxv

Alma Mater Studiorum Università di Bologna DOTTORATO DI RICERCA IN PSICOLOGIA GENERALE E CLINICA. Ciclo xxv Alma Mater Studiorum Università di Bologna DOTTORATO DI RICERCA IN PSICOLOGIA GENERALE E CLINICA Ciclo xxv Settore Concorsuale di afferenza: 11/E4 Settore Scientifico disciplinare: M-PSI/08 THE IMPACT

More information

Cardiac rehabilitation

Cardiac rehabilitation Information For Patients & Carers Cardiac rehabilitation Liverpool Heart and Chest Hospital NHS Trust Thomas Drive Liverpool Merseyside L14 3PE Telephone: 0151-228 1616 www.lhch.nhs.uk This leaflet has

More information

EINSTEIN PE Data Summary & Perspectives on XARELTO (rivaroxaban) in ORS & NVAF. Recorded Webcast Update for Analysts and Investors March 26, 2012

EINSTEIN PE Data Summary & Perspectives on XARELTO (rivaroxaban) in ORS & NVAF. Recorded Webcast Update for Analysts and Investors March 26, 2012 EINSTEIN PE Data Summary & Perspectives on XARELTO (rivaroxaban) in ORS & NVAF Recorded Webcast Update for Analysts and Investors March 26, 2012 1 Webcast Presentation Agenda EINSTEIN PE Clinical Trial

More information

Coverage for preventive care

Coverage for preventive care Coverage for preventive care Understanding your preventive care coverage Preventive care, like screenings and immunizations, helps you and your family stay healthier and can help lower your overall out-of-pocket

More information

Carbohydrate and Lipid Disorders and Relevant Considerations in Persons with Spinal Cord Injury

Carbohydrate and Lipid Disorders and Relevant Considerations in Persons with Spinal Cord Injury Evidence Report/Technology Assessment Number 163 Carbohydrate and Lipid Disorders and Relevant Considerations in Persons with Spinal Cord Injury Prepared for: Agency for Healthcare Research and Quality

More information

The Challenge of Preventing and Treating Diabesity Los Angeles University of Best Practices

The Challenge of Preventing and Treating Diabesity Los Angeles University of Best Practices The Challenge of Preventing and Treating Diabesity Los Angeles University of Best Practices The Right Care Initiative Long Beach Memorial Hospital July 26, 2013 Francine Ratner Kaufman, MD Distinguished

More information

Your Guide to Medicare s Preventive Services

Your Guide to Medicare s Preventive Services Your Guide to Medicare s Preventive Services C E N T E R S F O R M E D I C A R E & M E D I C A I D S E R V I C E S This is the official government booklet with important information about: What disease

More information

Atrial Fibrillation. Gibtsawit Kidane Kimberly Pullen Jennifer Smith

Atrial Fibrillation. Gibtsawit Kidane Kimberly Pullen Jennifer Smith Atrial Fibrillation Gibtsawit Kidane Kimberly Pullen Jennifer Smith Background Our Patient D. B. is a 59 year old Caucasian male Successful business owner College educated New diagnosis of atrial fibrillation

More information

Goals 6/6/2014. Stroke Prevention in Atrial Fibrillation: New Oral Anti-Coagulants No More INRs. Ashkan Babaie, MD

Goals 6/6/2014. Stroke Prevention in Atrial Fibrillation: New Oral Anti-Coagulants No More INRs. Ashkan Babaie, MD Stroke Prevention in Atrial Fibrillation: New Oral Anti-Coagulants No More INRs Ashkan Babaie, MD Arrhythmia Service Providence Heart Clinic June 8 th, 2014 Goals Discuss the data behind approval of NOACs

More information

GetWell Insurance GENERAL CONDITIONS. GetWell Insurance is offered on an individual basis.

GetWell Insurance GENERAL CONDITIONS. GetWell Insurance is offered on an individual basis. GetWell Insurance GENERAL CONDITIONS GetWell Insurance is offered on an individual basis. Desjardins Insurance refers to Desjardins Financial Security Life Assurance Company. Table of contents 1. GetWell

More information

CIGI Direct Insurance Services, Inc. QUICK QUOTE CORONARY ANGIOPLASTY/CORONARY BYPASS

CIGI Direct Insurance Services, Inc. QUICK QUOTE CORONARY ANGIOPLASTY/CORONARY BYPASS QUICK QUOTE CORONARY ANGIOPLASTY/CORONARY BYPASS Amount of Insurance $ Type of Insurance 1. Has patient had: Date of last symptom, list date (or dates if more than one ) Angina pectoris (heart pain)? r

More information

J of Evolution of Med and Dent Sci/ eissn- 2278-4802, pissn- 2278-4748/ Vol. 4/ Issue 75/ Sept 17, 2015 Page 13049

J of Evolution of Med and Dent Sci/ eissn- 2278-4802, pissn- 2278-4748/ Vol. 4/ Issue 75/ Sept 17, 2015 Page 13049 CORRELATION BETWEEN CAROTID INTIMA MEDIA THICKNESS AND NEWLY DIAGNOSED HYPERTENSIVE PATIENTS Rupak Bhuyan 1, Gaurav Chayan Das 2, Arabinda Mandal 3, David Pegu 4, Indrani Deori 5, Sumit Ujawane 6, Stephenson

More information

Renal artery stenting: are there any indications left?

Renal artery stenting: are there any indications left? there any indications left? Luís Mendes Pedro, MD. PhD, FEBVS Lisbon Academic Medical Centre (University of Lisbon and Hospital Santa Maria) Instituto Cardiovascular de Lisboa Disclosures Speaker name:

More information

Tackling Chronic Disease

Tackling Chronic Disease Tackling Chronic Disease A Policy Framework for the Management of Chronic Diseases Hawkins House Dublin 2 Teach Haicin Baile Átha Cliath 2 Telephone (01) 6354000 www.dohc.ie ISBN: 978-1-40642135-4 Tackling

More information

ALBANY PLASTIC SURGEONS, PLLC 4 Executive Park Drive Albany NY 12203 (518) 438-1434 PATIENT INFORMATION FORM

ALBANY PLASTIC SURGEONS, PLLC 4 Executive Park Drive Albany NY 12203 (518) 438-1434 PATIENT INFORMATION FORM ALBANY PLASTIC SURGEONS, PLLC 4 Executive Park Drive Albany NY 12203 (518) 438-1434 PATIENT INFORMATION FORM Today s Date: PERSONAL INFORMATION First Name: Last Name: MI: Address: City: State/Province:

More information

Dorset Cardiac Centre

Dorset Cardiac Centre P a g e 1 Dorset Cardiac Centre Patients with Atrial Fibrillation/Flutter undergoing DC Cardioversion or Ablation procedures- Guidelines for Novel Oral Anti-coagulants (NOACS) licensed for this use February

More information

1990 Life Insurance and Diabetes

1990 Life Insurance and Diabetes ADS Position Statements 1990 Life Insurance and Diabetes John Carter, John Greenway, Royal Prince Alfred Hospital, Concord Hospital and Hornsby Hospital, NSW Page 1 LIFE INSURANCE AND DIABETES MELLITUS

More information

Cancer and Heart/Stroke coverage

Cancer and Heart/Stroke coverage Cancer and Heart/Stroke coverage Assurant Supplemental Coverage» Pays cash right to you You never expect a life-threatening illness like cancer, heart attack or stroke. But if the unexpected happens to

More information

Quiz 4 Arrhythmias summary statistics and question answers

Quiz 4 Arrhythmias summary statistics and question answers 1 Quiz 4 Arrhythmias summary statistics and question answers The correct answers to questions are indicated by *. All students were awarded 2 points for question #2 due to no appropriate responses for

More information

Antonio Colombo MD on behalf of the SECURITY Investigators

Antonio Colombo MD on behalf of the SECURITY Investigators Second Generation Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy - The SECURITY Randomized Clinical Trial Antonio Colombo MD on behalf of the SECURITY

More information

Cardiac Rehab and Primary Care: Avoiding Losses in Care Transitions. Neville Suskin Heart & Stroke Clinical Update 2012

Cardiac Rehab and Primary Care: Avoiding Losses in Care Transitions. Neville Suskin Heart & Stroke Clinical Update 2012 Cardiac Rehab and Primary Care: Avoiding Losses in Care Transitions Neville Suskin Heart & Stroke Clinical Update 2012 1 Disclosure Med. Director SJHC CR Co-principal of Lawson e-cr application LCVIS SJHC

More information

Cardiac Rehabilitation after Myocardial Infarction

Cardiac Rehabilitation after Myocardial Infarction SUPPLEMENT TO JAPI december 2011 VOL. 59 51 Cardiac Rehabilitation after Myocardial Infarction Aashish S Contractor * Abstract Cardiac rehabilitation / secondary prevention programs are recognized as integral

More information

Texas Health Insurance Coverage for Prevention and Screening of Cancer, Cardiovascular Disease, and Diabetes

Texas Health Insurance Coverage for Prevention and Screening of Cancer, Cardiovascular Disease, and Diabetes Texas Health Insurance Coverage for Prevention and Screening of Cancer, Cardiovascular Disease, and Diabetes Phyllis Gingiss, Dr.P.H. Victoria Mosier, M.A. Sandra Coombs Khurram Shahzad, B.S. June 2007

More information

Xarelto (Rivaroxaban)

Xarelto (Rivaroxaban) Xarelto (Rivaroxaban) Hightly selective, reversible, direct oral FXa inhibitor Maxium concentratiion after 2 to 4 hrs High bioavailability(66%),increase with food ( suggest with food) 1/3 from renal excretion,

More information

Chapter 3: Review of Literature Stroke

Chapter 3: Review of Literature Stroke Chapter 3: Review of Literature Stroke INTRODUCTION Cerebrovascular accident (also known as stroke) is a serious health problem in the United States and a leading cause of long-term disability. In this

More information

PROMISE & PITFALLS OF OUTCOMES RESEARCH USING EMR DATABASES. Richard L. Tannen, M.D., Mark Weiner, Dawei Xie

PROMISE & PITFALLS OF OUTCOMES RESEARCH USING EMR DATABASES. Richard L. Tannen, M.D., Mark Weiner, Dawei Xie PROMISE & PITFALLS OF OUTCOMES RESEARCH USING EMR DATABASES Richard L. Tannen, M.D., Mark Weiner, Dawei Xie GOALS OF STUDY Determine Whether Studies Using EMR Database Yield Valid Outcome Assessment Major

More information

Atrial Fibrillation Centre

Atrial Fibrillation Centre About this guide We have prepared this guide to help you to: learn about atrial fibrillation manage atrial fibrillation and reduce the risk of stroke find out about medicines and other treatment options

More information